| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | KLHL2 PRAMEF5 PRAMEF9 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 SKP2 PRAMEF27 | 5.39e-09 | 82 | 189 | 10 | GO:1990756 |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | KLHL2 PRAMEF5 PRAMEF9 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 SKP2 PRAMEF27 | 2.29e-08 | 95 | 189 | 10 | GO:0140767 |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | PRAMEF5 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 CNOT1 PRAMEF27 | 4.62e-08 | 55 | 189 | 8 | GO:0042974 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | MKKS PRAMEF5 SRF JUP FBP1 MMS19 SETD3 MED12 PRAMEF11 PRAMEF6 TBP PRAMEF20 PRAMEF15 PRAMEF4 CNOT1 PRAMEF27 TP53BP1 | 4.98e-07 | 417 | 189 | 17 | GO:0061629 |
| GeneOntologyMolecularFunction | nuclear receptor binding | PRAMEF5 JUP MMS19 MED12 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 CNOT1 PRAMEF27 | 1.75e-06 | 187 | 189 | 11 | GO:0016922 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 8.23e-06 | 5 | 189 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | MKKS PRAMEF5 SRF JUP FBP1 MMS19 SETD3 MED12 PRAMEF11 PRAMEF6 TBP PRAMEF20 PRAMEF15 PRAMEF4 MAPK3 CNOT1 PRAMEF27 TP53BP1 | 1.12e-05 | 582 | 189 | 18 | GO:0140297 |
| GeneOntologyMolecularFunction | transcription factor binding | MKKS PRAMEF5 SRF JUP FBP1 MMS19 SETD3 MED12 PRAMEF11 PRAMEF6 TBP PRAMEF20 PRAMEF15 PRAMEF4 MAPK3 ENO1 CNOT1 PRAMEF27 TP53BP1 | 1.01e-04 | 753 | 189 | 19 | GO:0008134 |
| GeneOntologyBiologicalProcess | blastocyst formation | PRAMEF5 SRF PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 CNOT1 | 6.29e-07 | 78 | 191 | 8 | GO:0001825 |
| GeneOntologyBiologicalProcess | siRNA-mediated post-transcriptional gene silencing | 3.11e-06 | 4 | 191 | 3 | GO:0140766 | |
| GeneOntologyBiologicalProcess | siRNA-mediated gene silencing by mRNA destabilization | 3.11e-06 | 4 | 191 | 3 | GO:0090625 | |
| GeneOntologyBiologicalProcess | trachea development | 4.57e-05 | 22 | 191 | 4 | GO:0060438 | |
| GeneOntologyBiologicalProcess | RNA secondary structure unwinding | 6.30e-05 | 9 | 191 | 3 | GO:0010501 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 6.63e-05 | 108 | 191 | 7 | GO:0035019 | |
| GeneOntologyBiologicalProcess | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 8.85e-05 | 49 | 191 | 5 | GO:0031146 | |
| GeneOntologyBiologicalProcess | RISC complex assembly | 8.94e-05 | 10 | 191 | 3 | GO:0070922 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | PRAMEF5 PRAMEF9 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF27 | 1.06e-08 | 47 | 193 | 8 | GO:0031462 |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | KLHL2 PRAMEF5 PRAMEF9 FBXL21P FBXL3 FBXL18 PRAMEF11 PRAMEF6 PRAMEF20 FBXL14 PRAMEF15 PRAMEF4 SKP2 PRAMEF27 | 1.13e-08 | 212 | 193 | 14 | GO:0031461 |
| GeneOntologyCellularComponent | ubiquitin ligase complex | KLHL2 PRAMEF5 PRAMEF9 FBXL21P FBXL3 FBXL18 MED12 PRAMEF11 PRAMEF6 PRAMEF20 FBXL14 PRAMEF15 PRAMEF4 SKP2 PRAMEF27 | 1.03e-06 | 352 | 193 | 15 | GO:0000151 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | KLHL2 PRAMEF5 PRAMEF9 FAM98B FBXL21P FBXL3 AGO4 FBXL18 AGO3 MMS19 MED12 PRAMEF11 PRAMEF6 TBP PRAMEF20 FBXL14 PRAMEF15 PRAMEF4 TRAPPC8 SKP2 AGO1 TRAPPC12 CNOT1 PRAMEF27 | 1.13e-05 | 972 | 193 | 24 | GO:0140535 |
| GeneOntologyCellularComponent | RISC-loading complex | 8.86e-05 | 10 | 193 | 3 | GO:0070578 | |
| GeneOntologyCellularComponent | cilium | MKKS PRAMEF5 QRICH2 ADCY3 ARL6 BSG GLI3 KCNJ10 CPLANE1 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 CRB1 MAPRE1 CCDC88A DNAAF1 ANKS3 PMFBP1 | 2.54e-04 | 898 | 193 | 20 | GO:0005929 |
| GeneOntologyCellularComponent | SCF ubiquitin ligase complex | 4.74e-04 | 70 | 193 | 5 | GO:0019005 | |
| GeneOntologyCellularComponent | transferase complex | KLHL2 PRAMEF5 PRAMEF9 CCNO EXT2 FBXL21P FBXL3 FBXL18 MMS19 MED12 PRAMEF11 PRAMEF6 TBP PRAMEF20 FBXL14 PRAMEF15 PRAMEF4 SKP2 PIK3R6 PRAMEF27 | 6.17e-04 | 963 | 193 | 20 | GO:1990234 |
| MousePheno | abnormal spermatogonia proliferation | 6.84e-07 | 47 | 152 | 7 | MP:0002685 | |
| MousePheno | abnormal gametogenesis | MKKS ADAD1 PRAMEF5 QRICH2 ADCY3 FANCD2 ARL6 GK NF1 AGO4 BSG RIMBP3C HERC2 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 APOB PRAMEF4 RNF17 NLRP2 RIMBP3 MAPK1 RIMBP3B SLC25A28 NLRP4 CTSV PRAMEF27 PMFBP1 | 3.77e-06 | 1070 | 152 | 29 | MP:0001929 |
| MousePheno | abnormal sperm number | ADAD1 PRAMEF5 QRICH2 FANCD2 GK NF1 AGO4 BSG RIMBP3C HERC2 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 APOB PRAMEF4 RNF17 RIMBP3 RIMBP3B SLC25A28 PRAMEF27 | 3.93e-06 | 624 | 152 | 21 | MP:0002673 |
| MousePheno | abnormal gametes | MKKS ADAD1 PRAMEF5 QRICH2 FANCD2 ARL6 GK NF1 AGO4 BSG RIMBP3C HERC2 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 APOB PRAMEF4 RNF17 RIMBP3 RIMBP3B SLC25A28 PRAMEF27 PMFBP1 | 3.95e-06 | 785 | 152 | 24 | MP:0001124 |
| MousePheno | abnormal jejunum morphology | 4.92e-06 | 41 | 152 | 6 | MP:0004002 | |
| MousePheno | abnormal spermatogenesis | MKKS ADAD1 PRAMEF5 QRICH2 ADCY3 FANCD2 ARL6 GK NF1 AGO4 BSG RIMBP3C HERC2 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 APOB PRAMEF4 RNF17 RIMBP3 RIMBP3B SLC25A28 CTSV PRAMEF27 PMFBP1 | 5.10e-06 | 910 | 152 | 26 | MP:0001156 |
| MousePheno | increased central memory CD4-positive, alpha-beta T cell number | 5.12e-06 | 24 | 152 | 5 | MP:0010841 | |
| MousePheno | abnormal duodenum morphology | 5.79e-06 | 64 | 152 | 7 | MP:0003271 | |
| MousePheno | abnormal germ cell morphology | MKKS ADAD1 PRAMEF5 QRICH2 FANCD2 ARL6 GK NF1 AGO4 BSG RIMBP3C HERC2 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 APOB PRAMEF4 RNF17 NLRP2 RIMBP3 RIMBP3B SLC25A28 NLRP4 PRAMEF27 PMFBP1 | 1.02e-05 | 946 | 152 | 26 | MP:0002208 |
| MousePheno | abnormal foam cell morphology | MKKS ADAD1 PRAMEF5 QRICH2 FANCD2 ARL6 GK NF1 AGO4 BSG RIMBP3C HERC2 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 APOB PRAMEF4 RNF17 NLRP2 RIMBP3 RIMBP3B SLC25A28 NLRP4 PRAMEF27 PMFBP1 | 1.18e-05 | 954 | 152 | 26 | MP:0009840 |
| MousePheno | abnormal central memory CD4-positive, alpha-beta T cell number | 1.63e-05 | 30 | 152 | 5 | MP:0012771 | |
| MousePheno | abnormal central memory CD4-positive, alpha-beta T cell morphology | 1.63e-05 | 30 | 152 | 5 | MP:0010840 | |
| MousePheno | abnormal male germ cell morphology | MKKS ADAD1 PRAMEF5 QRICH2 FANCD2 ARL6 GK NF1 AGO4 BSG RIMBP3C HERC2 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 APOB PRAMEF4 RNF17 RIMBP3 RIMBP3B SLC25A28 PRAMEF27 PMFBP1 | 1.79e-05 | 859 | 152 | 24 | MP:0006362 |
| MousePheno | decreased male germ cell number | ADAD1 PRAMEF5 QRICH2 FANCD2 GK AGO4 BSG RIMBP3C HERC2 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 APOB PRAMEF4 RNF17 RIMBP3 RIMBP3B SLC25A28 PRAMEF27 | 2.01e-05 | 640 | 152 | 20 | MP:0004901 |
| MousePheno | infertility | MKKS ADAD1 PRAMEF5 HK1 TLR6 QRICH2 FANCD2 ARL6 CEP68 ARID1B GK ANTXR2 BSG RIMBP3C HERC2 HERC1 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 RNF17 TG RIMBP3 PAH LRRCC1 RIMBP3B PRAMEF27 PMFBP1 | 2.78e-05 | 1188 | 152 | 29 | MP:0001924 |
| MousePheno | abnormal CD4-positive, alpha-beta memory T cell morphology | 2.80e-05 | 55 | 152 | 6 | MP:0010834 | |
| MousePheno | male infertility | MKKS ADAD1 PRAMEF5 TLR6 QRICH2 ARL6 CEP68 ARID1B GK BSG RIMBP3C HERC2 HERC1 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 RNF17 TG RIMBP3 LRRCC1 RIMBP3B PRAMEF27 PMFBP1 | 2.89e-05 | 944 | 152 | 25 | MP:0001925 |
| MousePheno | increased CD4-positive, alpha-beta memory T cell number | 4.19e-05 | 59 | 152 | 6 | MP:0010835 | |
| MousePheno | increased circulating amylase level | PRAMEF5 HERC1 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 EPG5 | 4.60e-05 | 119 | 152 | 8 | MP:0008806 |
| MousePheno | abnormal circulating amylase level | PRAMEF5 HERC1 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 EPG5 USP54 | 5.14e-05 | 156 | 152 | 9 | MP:0008804 |
| MousePheno | decreased germ cell number | ADAD1 PRAMEF5 QRICH2 FANCD2 GK AGO4 BSG RIMBP3C HERC2 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 APOB PRAMEF4 RNF17 RIMBP3 RIMBP3B SLC25A28 PRAMEF27 | 5.48e-05 | 687 | 152 | 20 | MP:0002209 |
| MousePheno | abnormal male reproductive system physiology | MKKS ADAD1 PRAMEF5 TLR6 QRICH2 ADCY3 ARL6 CEP68 ARID1B GK NF1 AGO4 BSG RIMBP3C HERC2 HERC1 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 APOB PRAMEF4 RNF17 TG RIMBP3 LRRCC1 RIMBP3B SLC25A28 PRAMEF27 PMFBP1 | 8.49e-05 | 1329 | 152 | 30 | MP:0003698 |
| MousePheno | abnormal CD4-positive, alpha-beta memory T cell number | 1.51e-04 | 74 | 152 | 6 | MP:0012769 | |
| MousePheno | increased kidney weight | 1.84e-04 | 145 | 152 | 8 | MP:0003917 | |
| MousePheno | increased male germ cell apoptosis | PRAMEF5 AGO4 BSG PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF27 | 2.22e-04 | 189 | 152 | 9 | MP:0014052 |
| MousePheno | azoospermia | PRAMEF5 FANCD2 BSG PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 RNF17 PRAMEF27 | 3.36e-04 | 244 | 152 | 10 | MP:0005159 |
| MousePheno | kinked sperm flagellum | 3.48e-04 | 56 | 152 | 5 | MP:0009237 | |
| MousePheno | abnormal kidney weight | GAK PRAMEF5 ARID1B BSG PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 | 4.50e-04 | 208 | 152 | 9 | MP:0002707 |
| MousePheno | absent gametes | PRAMEF5 FANCD2 BSG PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 RNF17 PRAMEF27 | 4.90e-04 | 256 | 152 | 10 | MP:0001117 |
| Domain | - | PRAMEF25 PRAMEF5 CARMIL3 TLR7 TLR6 FBXL21P FBXL3 PRAMEF6 LRRC41 PRAMEF20 FBXL14 PRAMEF15 PRAMEF4 SKP2 NLRP2 LRRC8D LINGO1 LRRCC1 LRRC28 DNAAF1 NLRP4 PRAMEF27 LRRD1 | 1.38e-13 | 321 | 186 | 23 | 3.80.10.10 |
| Domain | L_dom-like | PRAMEF25 PRAMEF5 CARMIL3 TLR7 TLR6 FBXL21P FBXL3 PRAMEF6 LRRC41 PRAMEF20 FBXL14 PRAMEF15 PRAMEF4 SKP2 NLRP2 LRRC8D LINGO1 LRRCC1 LRRC28 DNAAF1 NLRP4 PRAMEF27 LRRD1 | 2.18e-13 | 328 | 186 | 23 | IPR032675 |
| Domain | PRAME_family | 3.95e-10 | 19 | 186 | 7 | IPR026271 | |
| Domain | ARM-type_fold | DOCK5 JUP URB1 NF1 PLAA AP1B1 ANKAR DIAPH1 PDS5A MMS19 DOCK8 APOB HEATR1 WDFY4 THADA HEATR6 XPO7 | 5.31e-08 | 339 | 186 | 17 | IPR016024 |
| Domain | ARM-like | JUP ARID1B NF1 PLAA AP1B1 ANKAR PDS5A MMS19 MED12 TBP DOCK8 HEATR1 WDFY4 HEATR6 XPO7 | 8.88e-08 | 270 | 186 | 15 | IPR011989 |
| Domain | Leu-rich_rpt | CARMIL3 TLR7 TLR6 LRRC41 FBXL14 SKP2 NLRP2 LRRC8D LINGO1 LRRCC1 LRRC28 DNAAF1 NLRP4 LRRD1 | 5.85e-07 | 271 | 186 | 14 | IPR001611 |
| Domain | - | JUP ARID1B NF1 AP1B1 ANKAR PDS5A MMS19 MED12 TBP HEATR1 WDFY4 HEATR6 | 2.40e-06 | 222 | 186 | 12 | 1.25.10.10 |
| Domain | Argonaute_N | 3.86e-06 | 4 | 186 | 3 | IPR032474 | |
| Domain | Argonaute_Mid_dom | 3.86e-06 | 4 | 186 | 3 | IPR032473 | |
| Domain | ArgoL2 | 3.86e-06 | 4 | 186 | 3 | IPR032472 | |
| Domain | ArgoN | 3.86e-06 | 4 | 186 | 3 | PF16486 | |
| Domain | ArgoMid | 3.86e-06 | 4 | 186 | 3 | PF16487 | |
| Domain | ArgoL2 | 3.86e-06 | 4 | 186 | 3 | PF16488 | |
| Domain | DUF1785 | 9.58e-06 | 5 | 186 | 3 | SM01163 | |
| Domain | LRR_1 | TLR7 TLR6 LRRC41 FBXL14 SKP2 LRRC8D LINGO1 LRRCC1 LRRC28 DNAAF1 LRRD1 | 1.27e-05 | 219 | 186 | 11 | PF00560 |
| Domain | ArgoL1 | 1.90e-05 | 6 | 186 | 3 | PF08699 | |
| Domain | ArgoL1 | 1.90e-05 | 6 | 186 | 3 | IPR014811 | |
| Domain | PIWI | 5.25e-05 | 8 | 186 | 3 | PS50822 | |
| Domain | Piwi | 5.25e-05 | 8 | 186 | 3 | SM00950 | |
| Domain | Piwi | 5.25e-05 | 8 | 186 | 3 | PF02171 | |
| Domain | Piwi | 5.25e-05 | 8 | 186 | 3 | IPR003165 | |
| Domain | PAZ | 7.81e-05 | 9 | 186 | 3 | PS50821 | |
| Domain | PAZ | 7.81e-05 | 9 | 186 | 3 | SM00949 | |
| Domain | PAZ | 7.81e-05 | 9 | 186 | 3 | PF02170 | |
| Domain | PAZ_dom | 7.81e-05 | 9 | 186 | 3 | IPR003100 | |
| Domain | MAPK_ERK1/2 | 9.86e-05 | 2 | 186 | 2 | IPR008349 | |
| Domain | FBOX | 1.65e-04 | 52 | 186 | 5 | SM00256 | |
| Domain | BRINP | 2.94e-04 | 3 | 186 | 2 | IPR033237 | |
| Domain | F-box | 5.44e-04 | 67 | 186 | 5 | PF00646 | |
| Domain | FBOX | 7.57e-04 | 72 | 186 | 5 | PS50181 | |
| Domain | F-box_dom | 9.12e-04 | 75 | 186 | 5 | IPR001810 | |
| Domain | F-box-like | 9.47e-04 | 44 | 186 | 4 | PF12937 | |
| Domain | Beta2_adaptin/TBP_C_dom | 1.44e-03 | 6 | 186 | 2 | IPR012295 | |
| Domain | - | 1.44e-03 | 6 | 186 | 2 | 3.30.310.10 | |
| Domain | NACHT | 1.49e-03 | 23 | 186 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 1.49e-03 | 23 | 186 | 3 | IPR007111 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 8.47e-07 | 34 | 138 | 6 | M46422 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 5.87e-06 | 13 | 138 | 4 | M46434 | |
| Pathway | BIOCARTA_DICER_PATHWAY | 9.05e-06 | 5 | 138 | 3 | M22079 | |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 1.80e-05 | 6 | 138 | 3 | MM14818 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.80e-05 | 6 | 138 | 3 | MM15083 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 2.14e-05 | 35 | 138 | 5 | M27190 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER | 2.14e-05 | 35 | 138 | 5 | M42525 | |
| Pathway | BIOCARTA_MAL_PATHWAY | 2.42e-05 | 18 | 138 | 4 | MM1482 | |
| Pathway | BIOCARTA_MAL_PATHWAY | 3.04e-05 | 19 | 138 | 4 | M10547 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 3.12e-05 | 7 | 138 | 3 | M46421 | |
| Pathway | REACTOME_SIGNALING_BY_ALK_IN_CANCER | 3.48e-05 | 93 | 138 | 7 | M42521 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 4.96e-05 | 8 | 138 | 3 | MM15082 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 7.39e-05 | 9 | 138 | 3 | M27340 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 7.39e-05 | 9 | 138 | 3 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 7.39e-05 | 9 | 138 | 3 | M46436 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 8.30e-05 | 46 | 138 | 5 | M39828 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 1.05e-04 | 10 | 138 | 3 | M48013 | |
| Pathway | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | 2.44e-04 | 13 | 138 | 3 | M593 | |
| Pathway | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | 2.44e-04 | 13 | 138 | 3 | MM14659 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 2.56e-04 | 32 | 138 | 4 | M48012 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 3.09e-04 | 14 | 138 | 3 | M668 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 3.09e-04 | 14 | 138 | 3 | MM1489 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | KLHL2 TLR6 FBXL3 FBXL18 HERC2 HERC1 LRRC41 FBXL14 SKP2 ASB13 CTSV CTSS | 3.64e-04 | 381 | 138 | 12 | M1066 |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 3.95e-04 | 137 | 138 | 7 | M48232 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 5.64e-04 | 17 | 138 | 3 | M27788 | |
| Pathway | BIOCARTA_BARRESTIN_SRC_PATHWAY | 5.64e-04 | 17 | 138 | 3 | M111 | |
| Pathway | BIOCARTA_BARRESTIN_SRC_PATHWAY | 5.64e-04 | 17 | 138 | 3 | MM1491 | |
| Pathway | WP_PDGF_PATHWAY | 6.11e-04 | 40 | 138 | 4 | M39555 | |
| Pathway | PID_ANTHRAX_PATHWAY | 6.73e-04 | 18 | 138 | 3 | M267 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | KLHL2 FBXL21P FBXL3 FBXL18 HERC2 HERC1 LRRC41 FBXL14 SKP2 ASB13 | 7.18e-04 | 299 | 138 | 10 | MM15711 |
| Pathway | WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING | 7.93e-04 | 19 | 138 | 3 | M39358 | |
| Pathway | BIOCARTA_ECM_PATHWAY | 7.93e-04 | 19 | 138 | 3 | M6355 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 7.93e-04 | 19 | 138 | 3 | M48238 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 8.26e-04 | 155 | 138 | 7 | MM14665 | |
| Pathway | WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING | 9.26e-04 | 20 | 138 | 3 | M39485 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_USP8_TO_EGFR_ERK_ACTH_SIGNALING_PATHWAY | 9.33e-04 | 5 | 138 | 2 | M49028 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY | 9.33e-04 | 5 | 138 | 2 | M49016 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_ERK_SIGNALING_PATHWAY | 9.33e-04 | 5 | 138 | 2 | M49004 | |
| Pathway | WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER | 9.33e-04 | 5 | 138 | 2 | M39621 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 9.33e-04 | 5 | 138 | 2 | MM1575 | |
| Pathway | BIOCARTA_ECM_PATHWAY | 1.07e-03 | 21 | 138 | 3 | MM1390 | |
| Pathway | REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND | 1.23e-03 | 22 | 138 | 3 | M27571 | |
| Pathway | REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND | 1.23e-03 | 22 | 138 | 3 | MM15284 | |
| Pathway | REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM | 1.23e-03 | 22 | 138 | 3 | M27243 | |
| Pathway | BIOCARTA_SAM68_PATHWAY | 1.39e-03 | 6 | 138 | 2 | M22052 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.39e-03 | 6 | 138 | 2 | M22062 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 1.39e-03 | 6 | 138 | 2 | M27559 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 1.39e-03 | 6 | 138 | 2 | MM15273 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 1.39e-03 | 6 | 138 | 2 | M47766 | |
| Pathway | BIOCARTA_SAM68_PATHWAY | 1.39e-03 | 6 | 138 | 2 | MM1567 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING | 1.39e-03 | 6 | 138 | 2 | M47936 | |
| Pathway | REACTOME_SIGNALING_BY_NODAL | 1.39e-03 | 6 | 138 | 2 | MM14517 | |
| Pathway | REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS | 1.41e-03 | 23 | 138 | 3 | M29824 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 1.41e-03 | 170 | 138 | 7 | M7494 | |
| Pubmed | PRAMEF5 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 NLRP2 NLRP4 PRAMEF27 | 2.73e-14 | 28 | 194 | 9 | 25089626 | |
| Pubmed | 1.10e-11 | 20 | 194 | 7 | 26694250 | ||
| Pubmed | PRAMEF5 IQGAP2 ADCY3 JUP URB1 ARID1B PLAA DIAPH1 HERC1 CPLANE1 UTRN FAM135A GOLGB1 PRAMEF11 WDFY1 PRAMEF6 PRAMEF20 PRAMEF15 APOB HEATR1 PRAMEF4 WDFY4 MAPRE1 MACF1 MAPK1 CNOT1 NLRP4 TP53BP1 | 1.65e-11 | 1084 | 194 | 28 | 11544199 | |
| Pubmed | 2.39e-11 | 22 | 194 | 7 | 31729367 | ||
| Pubmed | 6.65e-11 | 25 | 194 | 7 | 37451217 | ||
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 9.06e-11 | 26 | 194 | 7 | 18500982 | |
| Pubmed | KIF21B PDE2A IQGAP2 KCNA3 NF1 MDN1 AGO3 AP1B1 GPR158 KCNJ10 DIAPH1 KCNMA1 HERC2 GOLGB1 HECTD4 SART1 FRY CCDC88A AGO1 MACF1 MAPK1 MAPK3 ENO1 CNOT1 TP53BP1 | 2.00e-10 | 963 | 194 | 25 | 28671696 | |
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 2.75e-10 | 30 | 194 | 7 | 38786026 | |
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 3.28e-10 | 17 | 194 | 6 | 23565261 | |
| Pubmed | 3.28e-10 | 17 | 194 | 6 | 37781892 | ||
| Pubmed | 4.48e-10 | 76 | 194 | 9 | 27542412 | ||
| Pubmed | 4.89e-10 | 18 | 194 | 6 | 23894331 | ||
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 4.89e-10 | 18 | 194 | 6 | 39181896 | |
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 4.89e-10 | 18 | 194 | 6 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 4.89e-10 | 18 | 194 | 6 | 29731491 | |
| Pubmed | 4.89e-10 | 18 | 194 | 6 | 14675769 | ||
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 7.12e-10 | 19 | 194 | 6 | 28604677 | |
| Pubmed | 8.88e-10 | 35 | 194 | 7 | 19389355 | ||
| Pubmed | 1.01e-09 | 20 | 194 | 6 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 1.01e-09 | 20 | 194 | 6 | 21425410 | |
| Pubmed | PRAMEF5 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 MAPK1 MAPK3 | 1.22e-09 | 58 | 194 | 8 | 31598710 | |
| Pubmed | PRAMEF5 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 RNF17 NLRP4 | 1.41e-09 | 59 | 194 | 8 | 11279525 | |
| Pubmed | 2.60e-09 | 23 | 194 | 6 | 19480014 | ||
| Pubmed | HK1 ACACA IQGAP2 ARFIP2 BIRC6 ADCY9 DOCK5 ARL6 GLI3 PDS5A DCLRE1A FAM135A GOLGB1 ARL16 APOB CRB1 SART1 MAPRE1 THADA CCDC88A XPO7 | 3.09e-09 | 777 | 194 | 21 | 35844135 | |
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 4.52e-09 | 25 | 194 | 6 | 12620990 | |
| Pubmed | HK1 ACACA SRP72 BIRC6 URB1 NF1 MDN1 AP1B1 PDS5A HERC2 UTRN MED12 HEATR1 SART1 MACF1 EIF3I CNOT1 TP53BP1 XPO7 | 5.59e-09 | 653 | 194 | 19 | 22586326 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FAM120B MIS18BP1 HK1 ACACA BIRC6 ZGPAT JUP URB1 NF1 MDN1 FBXL18 PLAA DIAPH1 PDS5A MMS19 HERC2 UTRN MED12 HEATR1 KIF20B SART1 IGKC MACF1 MAPK1 EIF3I ENO1 TP53BP1 | 1.04e-08 | 1353 | 194 | 27 | 29467282 |
| Pubmed | GAK HK1 ATAD5 PEG10 EXT2 ADCY9 PASK ESYT2 JUP RINT1 URB1 MDN1 BSG CCDC138 HERC2 FAM135A GOLGB1 LRRC41 HEATR1 TRAPPC8 TUBGCP6 MAPRE1 AIFM2 THADA CCDC88A MACF1 MMAB TP53BP1 | 1.87e-08 | 1487 | 194 | 28 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TMEM120B ACACA SRF ANKMY1 SLC30A4 ADCY3 GALNT18 SLC25A37 DOCK5 ESYT2 ATXN1 GPR158 ANKAR KCNMA1 UTRN GOLGB1 LRRC41 NPAS2 WNT7B HECTD4 TEP1 LRRC8D ZNF708 THADA MACF1 CSMD1 CNOT1 XPO7 | 1.92e-08 | 1489 | 194 | 28 | 28611215 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | PRAMEF5 HK1 PASK JUP GLI3 ANKAR KCNMA1 MMS19 CPLANE1 GOLGB1 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 MAPRE1 ENO1 | 2.21e-08 | 564 | 194 | 17 | 21565611 |
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | 2.24e-08 | 32 | 194 | 6 | 37889087 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | KIF21B MIS18BP1 PRAMEF5 GALNT18 ADCY9 CBLIF ARID1B NF1 MDN1 AGO3 HERC1 FHIP1A PRAMEF11 PRAMEF6 VWA3A PRAMEF20 PRAMEF15 PRAMEF4 LRRC8D ZNF365 AGO1 MAPK1 CSMD1 SLC25A28 | 1.33e-07 | 1242 | 194 | 24 | 30973865 |
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | PRAMEF5 AGO4 AGO3 GLI3 PRAMEF11 PRAMEF6 TRIM2 WNT7B PRAMEF20 PRAMEF15 PRAMEF4 TEP1 AGO1 NLRP4 | 1.34e-07 | 424 | 194 | 14 | 21731673 |
| Pubmed | Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk. | 1.71e-07 | 3 | 194 | 3 | 23221339 | |
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 27358402 | ||
| Pubmed | TGFβ pathway is required for viable gestation of Fanconi anemia embryos. | 1.92e-07 | 10 | 194 | 4 | 36441774 | |
| Pubmed | 1.92e-07 | 10 | 194 | 4 | 18952847 | ||
| Pubmed | 2.17e-07 | 46 | 194 | 6 | 17287250 | ||
| Pubmed | PNMA1 ATAD5 ADCY9 FANCD2 PASK ARID1B AGO3 ATXN1 GLI3 DIAPH1 MMS19 LRRC41 TBP AOX1 TEP1 TUBGCP6 SART1 THADA MACF1 USP54 CSMD1 ANKS3 | 3.31e-07 | 1116 | 194 | 22 | 31753913 | |
| Pubmed | PRAMEF5 BIRC6 PLAA FHIP1A PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 NLRP2 HEATR6 NLRP4 | 3.44e-07 | 326 | 194 | 12 | 17015433 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 3.61e-07 | 50 | 194 | 6 | 31806660 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MIS18BP1 ACACA ARFIP2 ESYT2 RINT1 AGO3 CCDC138 MINDY4 HERC2 CPLANE1 FHIP1A RIMBP3 MAPRE1 CCDC88A AGO1 WDCP LRRCC1 USP54 CNOT1 | 3.62e-07 | 853 | 194 | 19 | 28718761 |
| Pubmed | 6.53e-07 | 30 | 194 | 5 | 35682694 | ||
| Pubmed | Molecular dissection of human Argonaute proteins by DNA shuffling. | 6.81e-07 | 4 | 194 | 3 | 23748378 | |
| Pubmed | 6.81e-07 | 4 | 194 | 3 | 18694962 | ||
| Pubmed | Slicing-independent RISC activation requires the argonaute PAZ domain. | 6.81e-07 | 4 | 194 | 3 | 22795694 | |
| Pubmed | Importance of translation and nonnucleolytic ago proteins for on-target RNA interference. | 6.81e-07 | 4 | 194 | 3 | 18771919 | |
| Pubmed | Ephrin-A5 suppresses neurotrophin evoked neuronal motility, ERK activation and gene expression. | 6.81e-07 | 4 | 194 | 3 | 22022520 | |
| Pubmed | Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. | 6.81e-07 | 4 | 194 | 3 | 15260970 | |
| Pubmed | 6.81e-07 | 4 | 194 | 3 | 15125795 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 6.81e-07 | 4 | 194 | 3 | 19091768 | |
| Pubmed | Signal pathway of 17beta-estradiol-induced MUC5B expression in human airway epithelial cells. | 6.81e-07 | 4 | 194 | 3 | 18688042 | |
| Pubmed | 6.81e-07 | 4 | 194 | 3 | 19966796 | ||
| Pubmed | A Requirement for Argonaute 4 in Mammalian Antiviral Defense. | 6.81e-07 | 4 | 194 | 3 | 32049003 | |
| Pubmed | 1.25e-06 | 34 | 194 | 5 | 26220403 | ||
| Pubmed | ZFYVE16 PEG10 SRP72 JUP ARID1B ANTXR2 AP1B1 DIAPH1 HERC2 HERC1 UTRN GOLGB1 DOCK8 EPG5 MACF1 | 1.33e-06 | 591 | 194 | 15 | 15231748 | |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | KIF21B BRINP3 PRAMEF25 PRAMEF5 PRAMEF9 KCNJ10 EPS8L3 PRAMEF11 PRAMEF6 PRAMEF20 HEATR1 PRAMEF4 LRRC8D OR6P1 CRB1 AGO1 BRINP2 MACF1 ENO1 CTSS | 1.50e-06 | 1031 | 194 | 20 | 16710414 |
| Pubmed | 1.69e-06 | 5 | 194 | 3 | 19393748 | ||
| Pubmed | 1.69e-06 | 5 | 194 | 3 | 20729213 | ||
| Pubmed | 1.69e-06 | 5 | 194 | 3 | 12414724 | ||
| Pubmed | 1.69e-06 | 5 | 194 | 3 | 19324964 | ||
| Pubmed | 1.69e-06 | 5 | 194 | 3 | 12526743 | ||
| Pubmed | 1.69e-06 | 5 | 194 | 3 | 21903164 | ||
| Pubmed | Differential expression of components of the microRNA machinery during mouse organogenesis. | 1.69e-06 | 5 | 194 | 3 | 16036130 | |
| Pubmed | 1.69e-06 | 5 | 194 | 3 | 28934393 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 1.69e-06 | 5 | 194 | 3 | 17855024 | |
| Pubmed | 1.69e-06 | 5 | 194 | 3 | 12469121 | ||
| Pubmed | MIS18BP1 ZFYVE16 GLI3 UTRN FAM135A GOLGB1 CCDC88A MACF1 USP54 CNOT1 | 2.50e-06 | 263 | 194 | 10 | 34702444 | |
| Pubmed | GAK EXT2 BIRC6 ADCY3 ESYT2 NF1 MDN1 AGO4 AGO3 BSG MMS19 HERC2 MED12 GOLGB1 LRRC41 DOCK8 HEATR1 LRRC8D TUBGCP6 ENO1 CNOT1 | 2.67e-06 | 1168 | 194 | 21 | 19946888 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MKKS FAM120B ACACA IQGAP2 EXT2 FAM98B QRICH2 PASK JUP BSG PDS5A MMS19 HERC2 HERC1 PREX1 HEATR1 CRB1 WDCP IGKC EIF3I CNOT1 XPO7 | 3.31e-06 | 1284 | 194 | 22 | 17353931 |
| Pubmed | Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. | 3.38e-06 | 6 | 194 | 3 | 14592976 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 10. | HK1 GPR158 KCNMA1 DCLRE1A MMS19 ZNF365 KIF20B ASB13 AIFM2 USP54 SLC25A28 | 4.28e-06 | 345 | 194 | 11 | 15164054 |
| Pubmed | BIRC6 CEP68 SAMD9L PDS5A FAM135A PREX1 MED12 PCYOX1 TRAPPC8 WDFY4 THADA LRRCC1 MACF1 | 4.57e-06 | 493 | 194 | 13 | 15368895 | |
| Pubmed | 5.34e-06 | 225 | 194 | 9 | 12168954 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | SRP72 FANCD2 CEP68 URB1 MDN1 PLAA HERC2 GOLGB1 PCYOX1 LRRC41 HEATR1 HEATR6 USP54 MAPK1 MAPK3 EIF3I | 5.81e-06 | 754 | 194 | 16 | 33060197 |
| Pubmed | 5.88e-06 | 7 | 194 | 3 | 25121610 | ||
| Pubmed | 5.88e-06 | 7 | 194 | 3 | 34907157 | ||
| Pubmed | 5.88e-06 | 7 | 194 | 3 | 19536157 | ||
| Pubmed | 5.88e-06 | 7 | 194 | 3 | 19383768 | ||
| Pubmed | 5.88e-06 | 7 | 194 | 3 | 16906226 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 5.88e-06 | 7 | 194 | 3 | 19470757 | |
| Pubmed | 5.88e-06 | 7 | 194 | 3 | 9949213 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | PNMA1 IQGAP2 ATAD5 SRP72 BIRC6 URB1 MDN1 HERC2 MED12 HEATR1 KIF20B SART1 CKAP2L MACF1 EIF3I CNOT1 | 6.31e-06 | 759 | 194 | 16 | 35915203 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | PRAMEF5 ACACA BIRC6 MDN1 UTRN PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 HECTD4 PRAMEF4 | 6.92e-06 | 363 | 194 | 11 | 14691545 |
| Pubmed | ZFYVE16 ATAD5 BIRC6 ADCY9 FANCD2 ESYT2 RINT1 ARID1B BSG CCDC138 KCNMA1 HERC2 HERC1 UTRN FBXL14 CCDC88A MAPK1 MAPK3 CNOT1 | 7.40e-06 | 1049 | 194 | 19 | 27880917 | |
| Pubmed | 9.38e-06 | 8 | 194 | 3 | 36001969 | ||
| Pubmed | Mili interacts with tudor domain-containing protein 1 in regulating spermatogenesis. | 9.38e-06 | 8 | 194 | 3 | 19345100 | |
| Pubmed | Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation. | 9.38e-06 | 8 | 194 | 3 | 22916010 | |
| Pubmed | 9.38e-06 | 8 | 194 | 3 | 29021386 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | FANCD2 PASK ESYT2 JUP EPS8L3 HERC2 SETD3 MED12 SKP2 SART1 FRY WDCP MAPK1 MAPK3 EIF3I | 9.40e-06 | 695 | 194 | 15 | 23602568 |
| Pubmed | ZFYVE16 SRP72 ADCY9 ESYT2 JUP KCNA3 BSG PDS5A FAM135A MED12 GOLGB1 CCDC88A MACF1 ENO1 CNOT1 | 1.17e-05 | 708 | 194 | 15 | 39231216 | |
| Pubmed | Identification of eight members of the Argonaute family in the human genome. | 1.40e-05 | 9 | 194 | 3 | 12906857 | |
| Pubmed | 1.40e-05 | 9 | 194 | 3 | 26460546 | ||
| Pubmed | 1.40e-05 | 9 | 194 | 3 | 14530346 | ||
| Pubmed | GAK HK1 JUP ARID1B MDN1 PLAA PDS5A MMS19 MUC5B HEATR6 IGKC MACF1 ENO1 XPO7 | 1.46e-05 | 634 | 194 | 14 | 34591612 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | MIS18BP1 EXT2 ZNF227 ESYT2 JUP RINT1 ARID1B BSG GLI3 PDS5A MED12 GOLGB1 HEATR1 SART1 HAGH EIF3I ENO1 CNOT1 TP53BP1 XPO7 | 1.47e-05 | 1203 | 194 | 20 | 29180619 |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ACACA CARMIL3 DOCK5 AP1B1 EPS8L3 HERC2 CPLANE1 UTRN FHIP1A IL18BP HEATR1 CKAP2L NEK11 | 1.52e-05 | 552 | 194 | 13 | 10737800 |
| Pubmed | ACACA PEG10 SRP72 ESYT2 JUP MDN1 BSG PDS5A MMS19 CCDC88A ENO1 | 1.67e-05 | 399 | 194 | 11 | 37536630 | |
| Pubmed | GAK HK1 IQGAP2 SRP72 FAM98B FANCD2 ESYT2 RINT1 URB1 MDN1 BSG PDS5A MMS19 TBP HEATR1 SKP2 THADA IGKC EIF3I SLC25A28 ENO1 CNOT1 | 1.97e-05 | 1440 | 194 | 22 | 30833792 | |
| Pubmed | Borealin/CDCA8 deficiency alters thyroid development and results in papillary tumor-like structures. | 1.99e-05 | 10 | 194 | 3 | 37964961 | |
| Interaction | ATOH1 interactions | 4.81e-08 | 80 | 184 | 9 | int:ATOH1 | |
| Interaction | PRAMEF4 interactions | 7.49e-07 | 3 | 184 | 3 | int:PRAMEF4 | |
| Interaction | STX6 interactions | GAK ZFYVE16 ARFIP2 ADCY9 ESYT2 JUP RINT1 AP1B1 BSG UTRN FAM135A GOLGB1 TRAPPC8 CCDC88A CKAP2L MACF1 ENO1 | 8.11e-07 | 448 | 184 | 17 | int:STX6 |
| Interaction | CD70 interactions | 3.06e-06 | 166 | 184 | 10 | int:CD70 | |
| Interaction | CAV1 interactions | PDE2A HK1 IQGAP2 ZFYVE16 ADCY3 ADCY9 FANCD2 ESYT2 JUP KCNA3 NF1 PLAA BSG KCNMA1 UTRN FAM135A GOLGB1 CCDC88A MACF1 MAPK1 MAPK3 | 3.06e-06 | 724 | 184 | 21 | int:CAV1 |
| Interaction | PFN1 interactions | BIRC6 FANCD2 ESYT2 KCNA3 NF1 DIAPH1 FAM135A GOLGB1 DOCK8 THADA MACF1 HAGH MAPK3 ENO1 CNOT1 TP53BP1 | 1.85e-05 | 509 | 184 | 16 | int:PFN1 |
| Interaction | CTNNA1 interactions | FANCD2 ZGPAT JUP RINT1 KCNA3 FBP1 HERC2 UTRN MAPRE1 CCDC88A MACF1 CTSV XPO7 | 1.92e-05 | 347 | 184 | 13 | int:CTNNA1 |
| Interaction | OPALIN interactions | 2.32e-05 | 209 | 184 | 10 | int:OPALIN | |
| Interaction | TDRD1 interactions | 2.34e-05 | 19 | 184 | 4 | int:TDRD1 | |
| Interaction | SCN2B interactions | 2.65e-05 | 95 | 184 | 7 | int:SCN2B | |
| Interaction | DCLRE1A interactions | 2.91e-05 | 20 | 184 | 4 | int:DCLRE1A | |
| Interaction | USO1 interactions | GAK FANCD2 CEP68 KCNA3 ATXN1 PDS5A GOLGB1 CEACAM16 MAPK3 XPO7 | 2.95e-05 | 215 | 184 | 10 | int:USO1 |
| Interaction | PROKR1 interactions | 3.56e-05 | 21 | 184 | 4 | int:PROKR1 | |
| Interaction | PRAMEF5 interactions | 4.05e-05 | 8 | 184 | 3 | int:PRAMEF5 | |
| Interaction | STK11 interactions | HK1 BIRC6 FBP1 PDS5A MMS19 HERC2 FBXL14 MUC5B SKP2 MAPRE1 C8orf76 MAPK3 | 4.78e-05 | 326 | 184 | 12 | int:STK11 |
| Interaction | NPTN interactions | FANCD2 RINT1 MDN1 BSG PDS5A MMS19 HEATR1 THADA HEATR6 BRINP2 XPO7 | 5.20e-05 | 278 | 184 | 11 | int:NPTN |
| Interaction | SIRT7 interactions | HK1 ACACA SRP72 BIRC6 URB1 NF1 MDN1 AP1B1 PDS5A HERC2 UTRN MED12 HEATR1 SART1 MACF1 EIF3I CNOT1 TP53BP1 XPO7 | 5.34e-05 | 744 | 184 | 19 | int:SIRT7 |
| Interaction | HDAC4 interactions | PNMA1 ACACA CARMIL3 SRF RINT1 NF1 AGO3 ATXN1 GPR158 BSG DIAPH1 KCNMA1 HERC2 FRY AGO1 MAPK1 MAPK3 ENO1 TP53BP1 | 5.34e-05 | 744 | 184 | 19 | int:HDAC4 |
| Interaction | OCLN interactions | IQGAP2 ADCY9 ARL6 ESYT2 JUP KCNA3 BSG SIGLECL1 UTRN FAM135A GOLGB1 SLAMF1 CCDC88A MACF1 USP54 | 5.79e-05 | 500 | 184 | 15 | int:OCLN |
| Interaction | GPR17 interactions | TMEM120B FANCD2 RINT1 URB1 MDN1 PLAA PDS5A LRRC41 HEATR1 THADA XPO7 | 6.10e-05 | 283 | 184 | 11 | int:GPR17 |
| Interaction | RAB11A interactions | HK1 ZFYVE16 ARFIP2 SLC30A4 BIRC6 ADCY9 FANCD2 ESYT2 JUP ANTXR2 AP1B1 BSG USP32 FAM135A FHIP1A GOLGB1 WDFY1 TRAPPC8 CCDC88A HAGH | 7.51e-05 | 830 | 184 | 20 | int:RAB11A |
| Interaction | RAB35 interactions | IQGAP2 ADCY3 ADCY9 FANCD2 ESYT2 JUP BSG USP32 DIAPH1 UTRN FAM135A GOLGB1 MAPRE1 CCDC88A WDCP MACF1 | 7.63e-05 | 573 | 184 | 16 | int:RAB35 |
| Interaction | PRAMEF15 interactions | 8.29e-05 | 2 | 184 | 2 | int:PRAMEF15 | |
| Interaction | C3orf18 interactions | 9.01e-05 | 115 | 184 | 7 | int:C3orf18 | |
| Interaction | PDCD1 interactions | 9.16e-05 | 80 | 184 | 6 | int:PDCD1 | |
| Interaction | CCDC8 interactions | KLHL2 FANCD2 JUP NF1 MDN1 HERC2 UTRN GOLGB1 APOB HEATR1 SART1 AGO1 CKAP2L MACF1 ENO1 CNOT1 XPO7 | 1.13e-04 | 656 | 184 | 17 | int:CCDC8 |
| Interaction | SLC25A37 interactions | 1.17e-04 | 11 | 184 | 3 | int:SLC25A37 | |
| Interaction | HKDC1 interactions | 1.32e-04 | 54 | 184 | 5 | int:HKDC1 | |
| Interaction | BTG2 interactions | 1.34e-04 | 29 | 184 | 4 | int:BTG2 | |
| Interaction | CST3 interactions | 1.34e-04 | 29 | 184 | 4 | int:CST3 | |
| Interaction | AIFM2 interactions | 1.34e-04 | 29 | 184 | 4 | int:AIFM2 | |
| Interaction | APLNR interactions | 1.43e-04 | 211 | 184 | 9 | int:APLNR | |
| Interaction | TAGLN interactions | 1.76e-04 | 90 | 184 | 6 | int:TAGLN | |
| Interaction | CEP112 interactions | 1.98e-04 | 32 | 184 | 4 | int:CEP112 | |
| Interaction | C3orf20 interactions | 2.00e-04 | 13 | 184 | 3 | int:C3orf20 | |
| Interaction | CEP135 interactions | SRP72 CCDC138 HERC2 GOLGB1 KIF20B MAPRE1 CCDC88A USP54 CNOT1 CTSV | 2.08e-04 | 272 | 184 | 10 | int:CEP135 |
| Interaction | HSP90AA1 interactions | A1BG MKKS FBXL3 FANCD2 DOCK5 PASK JUP KCNA3 AGO4 FBXL18 AGO3 BSG DIAPH1 NPAS2 TRIM2 FBXL14 APOB SKP2 NLRP2 AGO1 MAPK1 MAPK3 ENO1 NLRP4 NEK11 | 2.15e-04 | 1263 | 184 | 25 | int:HSP90AA1 |
| Interaction | KRT8 interactions | BIRC6 FANCD2 ESYT2 BSG USP32 CCDC138 MAPRE1 ZNF708 THADA WDCP MAPK1 MAPK3 CNOT1 | 2.16e-04 | 441 | 184 | 13 | int:KRT8 |
| Interaction | DPYSL2 interactions | PDE2A IQGAP2 FANCD2 AP1B1 ATXN1 KCNMA1 HERC2 PREX1 MMAB CNOT1 XPO7 | 2.17e-04 | 327 | 184 | 11 | int:DPYSL2 |
| Interaction | C19orf25 interactions | 2.37e-04 | 95 | 184 | 6 | int:C19orf25 | |
| Cytoband | 1p36.21 | PRAMEF25 PRAMEF5 PRAMEF9 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 | 2.79e-10 | 63 | 194 | 8 | 1p36.21 |
| GeneFamily | PRAME family | PRAMEF25 PRAMEF5 PRAMEF9 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF27 | 3.00e-14 | 24 | 124 | 9 | 686 |
| GeneFamily | F-box and leucine rich repeat proteins | 2.61e-07 | 21 | 124 | 5 | 558 | |
| GeneFamily | Argonaute/PIWI family | 1.72e-05 | 8 | 124 | 3 | 408 | |
| GeneFamily | CD molecules|Toll like receptors | 2.03e-03 | 10 | 124 | 2 | 948 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.03e-03 | 10 | 124 | 2 | 53 | |
| GeneFamily | WD repeat domain containing | 2.21e-03 | 262 | 124 | 7 | 362 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.18e-03 | 43 | 124 | 3 | 409 | |
| GeneFamily | Mitogen-activated protein kinases | 3.46e-03 | 13 | 124 | 2 | 651 | |
| GeneFamily | Trafficking protein particle complex | 4.02e-03 | 14 | 124 | 2 | 772 | |
| GeneFamily | Cathepsins | 4.62e-03 | 15 | 124 | 2 | 470 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED | ADAD1 PRAMEF5 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 RNF17 | 8.71e-09 | 57 | 192 | 8 | MM1262 |
| Coexpression | KOHOUTEK_CCNT2_TARGETS | PRAMEF5 CCNO PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF27 | 1.46e-07 | 81 | 192 | 8 | MM938 |
| Coexpression | KINNEY_DNMT1_METHYLATION_TARGETS | 1.62e-07 | 34 | 192 | 6 | MM955 | |
| Coexpression | HUANG_GATA2_TARGETS_DN | PRAMEF5 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 SKP2 SLAMF1 | 6.42e-07 | 98 | 192 | 8 | MM942 |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | MIS18BP1 CENPK FANCD2 ARL6 PASK PLAA CCDC138 KIF20B CKAP2L MAPK1 | 2.37e-06 | 200 | 192 | 10 | M3580 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS | PRAMEF5 ZFYVE16 NF1 PRAMEF11 PRAMEF6 TPST1 PRAMEF20 PRAMEF15 PRAMEF4 | 7.65e-06 | 180 | 192 | 9 | MM612 |
| Coexpression | DESCARTES_ORGANOGENESIS_SCHWANN_CELL_PRECURSOR | 8.00e-06 | 98 | 192 | 7 | MM3656 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP | 1.71e-05 | 199 | 192 | 9 | M9366 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 1.71e-05 | 199 | 192 | 9 | M6028 | |
| Coexpression | GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN | 1.78e-05 | 200 | 192 | 9 | M9335 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | PRAMEF5 DOCK5 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF27 | 2.06e-05 | 156 | 192 | 8 | MM550 |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | KLHL2 MIS18BP1 PNMA1 SRF ARFIP2 ADCY9 FANCD2 CEP68 CCDC138 TBP DOCK8 HEATR1 ZNF365 KIF20B THADA HSD17B6 LRRCC1 CKAP2L RIMBP3B CNOT1 CTSV | 2.15e-05 | 1023 | 192 | 21 | M17122 |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN | 3.82e-05 | 170 | 192 | 8 | M6762 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2 | PNMA1 CCNO ARL6 PASK RINT1 USP32 CCDC138 HERC2 CPLANE1 AIFM2 LINGO1 DNAAF1 NEK11 | 4.79e-05 | 471 | 192 | 13 | M3062 |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | PRAMEF5 MDN1 DIAPH1 PRAMEF11 PRAMEF6 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF27 | 5.68e-05 | 232 | 192 | 9 | MM1019 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.72e-05 | 180 | 192 | 8 | M8239 | |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP | 8.60e-05 | 98 | 192 | 6 | MM592 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KIF21B MIS18BP1 BIRC6 FBXL3 ESYT2 SAMD9L ANTXR2 ATXN1 DIAPH1 PDS5A HERC1 UTRN PREX1 DOCK8 HECTD4 TRAPPC8 SLAMF1 EPG5 MAPRE1 CCDC88A MACF1 MAPK1 ENO1 CNOT1 CTSS | 9.78e-05 | 1492 | 192 | 25 | M40023 |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP | 1.07e-04 | 197 | 192 | 8 | M9569 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP | 1.15e-04 | 199 | 192 | 8 | M9214 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP | 1.19e-04 | 200 | 192 | 8 | M8042 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 1.19e-04 | 200 | 192 | 8 | M7518 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | MIS18BP1 CENPK FANCD2 URB1 MDN1 PLAA CCDC138 SETD3 CPLANE1 FAM135A TPST1 HEATR1 TRAPPC8 RNF17 | 2.63e-06 | 361 | 180 | 14 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | MIS18BP1 FANCD2 PASK URB1 MDN1 PLAA SETD3 FAM135A HEATR1 TRAPPC8 RNF17 THADA C8orf76 | 5.64e-06 | 333 | 180 | 13 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | ADAD1 MIS18BP1 ACACA SLC30A4 CENPK FANCD2 ESYT2 URB1 MDN1 PLAA USP32 CCDC138 HERC1 SETD3 CPLANE1 FAM135A TPST1 HEATR1 TRAPPC8 RNF17 NLRP4 | 6.62e-06 | 820 | 180 | 21 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | BIRC6 ZGPAT ESYT2 SAMD9L KCNA3 MDN1 HERC1 UTRN MED12 SLAMF1 THADA MACF1 | 3.13e-05 | 336 | 180 | 12 | GSM538413_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | ADAD1 MIS18BP1 FANCD2 PASK URB1 MDN1 PLAA CCDC138 HERC1 SETD3 CPLANE1 FAM135A HEATR1 TRAPPC8 RNF17 KIF20B THADA C8orf76 NLRP4 | 6.14e-05 | 810 | 180 | 19 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | MIS18BP1 ATAD5 TLR7 FAM98B CENPK SLC25A37 FANCD2 ARL6 GK MDN1 AGO3 GLI3 CCDC138 PDS5A CPLANE1 CLEC9A HEATR1 KIF20B ASB13 AIFM2 CCDC88A LRRCC1 CKAP2L MACF1 TP53BP1 | 6.21e-05 | 1257 | 180 | 25 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | KIF21B PDE2A IQGAP2 ADCY3 DOCK5 ZGPAT ESYT2 ATXN1 UTRN PREX1 SLAMF1 MACF1 | 1.21e-04 | 387 | 180 | 12 | GSM538392_500 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | MIS18BP1 ATAD5 CENPK ZGPAT PREX1 WDFY4 KIF20B CCDC88A CKAP2L CTSS | 1.03e-08 | 187 | 194 | 10 | 73931a5ea73799095daff100b5f18853c57c74dc |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | IQGAP2 PASK ESYT2 ATXN1 UTRN PREX1 GOLGB1 HEATR1 THADA MACF1 | 1.19e-08 | 190 | 194 | 10 | 91ba66d4b56c59523485b17738e93f14bb00afa4 |
| ToppCell | facs-MAT-Fat-3m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-08 | 164 | 194 | 9 | b81498c3934e0d52bf0329dc745e02966f9d8613 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MIS18BP1 IQGAP2 SLC30A4 TEP1 WDFY4 KIF20B CCDC88A CKAP2L CTSS | 5.60e-08 | 168 | 194 | 9 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.47e-07 | 188 | 194 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.91e-07 | 194 | 194 | 9 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MIS18BP1 ATAD5 MCF2L2 CENPK KCNMA1 WDFY4 KIF20B CCDC88A BRINP2 | 2.18e-07 | 197 | 194 | 9 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-07 | 199 | 194 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 184 | 194 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.57e-06 | 185 | 194 | 8 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | mild-unassigned|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.64e-06 | 186 | 194 | 8 | 5b2e1a58916f392fa1156bf9210df528775248ff | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 2.00e-06 | 191 | 194 | 8 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 2.00e-06 | 191 | 194 | 8 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.08e-06 | 192 | 194 | 8 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.16e-06 | 193 | 194 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 2.33e-06 | 195 | 194 | 8 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | Immune-alveolar_macrophage_(MARCO_positive)|World / Lineage, Cell type, age group and donor | 2.33e-06 | 195 | 194 | 8 | f92114ef995e690a3bedc62c89c5fd6773d0d9f7 | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 2.33e-06 | 195 | 194 | 8 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.42e-06 | 196 | 194 | 8 | 51c48944149a89b98011a50fe81ca6664d5f0d44 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.42e-06 | 196 | 194 | 8 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.51e-06 | 197 | 194 | 8 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.51e-06 | 197 | 194 | 8 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.51e-06 | 197 | 194 | 8 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-06 | 198 | 194 | 8 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 2.61e-06 | 198 | 194 | 8 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-06 | 198 | 194 | 8 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-06 | 198 | 194 | 8 | 243109377d62d20c69e9d1fedc252156e90cda1e | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 2.61e-06 | 198 | 194 | 8 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | Immune|World / Lineage, Cell type, age group and donor | 2.61e-06 | 198 | 194 | 8 | 65681b54d13c6997bd90a1c2a12314a80e964fe3 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.81e-06 | 200 | 194 | 8 | 691b3edf7d8449556e8bf611662eb85772959f0f | |
| ToppCell | Parenchyma_COVID-19-Immune-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.81e-06 | 200 | 194 | 8 | fe27d56a05151049a64e35db5a144ff7952e6902 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.81e-06 | 200 | 194 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.81e-06 | 200 | 194 | 8 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.81e-06 | 200 | 194 | 8 | 36a110aa91a791fdf1142e7869e8aa0d342402d0 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.81e-06 | 200 | 194 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.81e-06 | 200 | 194 | 8 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Monophasic_Synovial_Sarcoma-5|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.32e-06 | 93 | 194 | 6 | 3e05ea0f8f4a7cdb78a596f47d563dc3c94d4d8e | |
| ToppCell | Mild/Remission-B_naive-5|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.98e-06 | 148 | 194 | 7 | 8b60f9843505660b3c9d5c7792976f902be4b94c | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-06 | 165 | 194 | 7 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.14e-06 | 168 | 194 | 7 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-05 | 171 | 194 | 7 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 1.07e-05 | 172 | 194 | 7 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 175 | 194 | 7 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-05 | 175 | 194 | 7 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-05 | 179 | 194 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-05 | 180 | 194 | 7 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | severe-Myeloid-Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.59e-05 | 183 | 194 | 7 | 60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.96e-05 | 189 | 194 | 7 | 1900e574870fc647bfa11c732a72f3d38aab717c | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.03e-05 | 190 | 194 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | COVID-19-kidney-Myeloid|kidney / Disease (COVID-19 only), tissue and cell type | 2.17e-05 | 192 | 194 | 7 | 441cd1ec171f643b28e1f6f9c04def629cc7391b | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 2.17e-05 | 192 | 194 | 7 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 193 | 194 | 7 | 3e3d7cb3e7242ec9c9677e07e303835649852b52 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 2.24e-05 | 193 | 194 | 7 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.24e-05 | 193 | 194 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 2.24e-05 | 193 | 194 | 7 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.32e-05 | 194 | 194 | 7 | d790cfff3664e46fe2fd2f6b0c26896799927845 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.38e-05 | 131 | 194 | 6 | 81efe8b0ca4377e557a42ddb12aecaf3f46b15bf | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 2.40e-05 | 195 | 194 | 7 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 195 | 194 | 7 | 09df40ff9b493170861b3f6e57a942a834655b5c | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 2.40e-05 | 195 | 194 | 7 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 2.48e-05 | 196 | 194 | 7 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.48e-05 | 196 | 194 | 7 | 1b7928f4eee94d4bb6ea410bab68a471dba12979 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 2.48e-05 | 196 | 194 | 7 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.48e-05 | 196 | 194 | 7 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.56e-05 | 197 | 194 | 7 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 197 | 194 | 7 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.56e-05 | 197 | 194 | 7 | b71da7f2fd8d526fb6e5d57e60fc08acdd8dbefb | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.64e-05 | 198 | 194 | 7 | ab70bf89690410221ec7aa3149bb50ac34433f99 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-05 | 198 | 194 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.73e-05 | 199 | 194 | 7 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-05 | 199 | 194 | 7 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-05 | 199 | 194 | 7 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.73e-05 | 199 | 194 | 7 | 22001aa733273e784051b7f750e07d99aaf7a225 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-TRAM-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.73e-05 | 199 | 194 | 7 | 5e4f02cfb90912e83257ed20f69c12650d28619e | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 200 | 194 | 7 | 8474e5d031d25bfb8461d39fa2053da01a6304fc | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 200 | 194 | 7 | ed785a6d08ca2b350dc3307b587eadfb2886d1f9 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 200 | 194 | 7 | a443e475e7a10c26a6173d1af961de6219e0e567 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma|TCGA-Testes / Sample_Type by Project: Shred V9 | 3.32e-05 | 139 | 194 | 6 | 6b58d01ce9d9ac23434333f9faf1bb0eef14ba90 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 148 | 194 | 6 | bbf4933582b50b3412c805de5ed137107c996236 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 148 | 194 | 6 | 79e376503a3f9504a1ec5af4a60a09cc80e19059 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 148 | 194 | 6 | 6543860e3207a7de92a35bb6004be51287582f7a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.88e-05 | 154 | 194 | 6 | ec56b7fb88e39041416c384f371c767f3b4e92fa | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 6.10e-05 | 155 | 194 | 6 | b0e456c4915076e1d38282e116a6eb3230ae80dc | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 158 | 194 | 6 | d3446fc98eff09c3626b47a2c90d07cd985378b5 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 158 | 194 | 6 | df614450e10629dc9115d7365397663e82f9e48f | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.79e-05 | 162 | 194 | 6 | 388670cf3acef17df971c0d8ae3ce14398945192 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.79e-05 | 162 | 194 | 6 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.79e-05 | 162 | 194 | 6 | 9333d923225df7bfdf6b3a4c32816751315aec50 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.62e-05 | 165 | 194 | 6 | d8b0a9b6f704b98e8f0412c11739879a26c036e2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-05 | 166 | 194 | 6 | 63dc58864268b4e7779e4c45155022556fc634f9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.21e-05 | 167 | 194 | 6 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.51e-05 | 168 | 194 | 6 | 2781dd6b369427a94c5059b44b4c8f023f5f2988 | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 9.51e-05 | 168 | 194 | 6 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.83e-05 | 169 | 194 | 6 | e3410ccb3f85811c75694e286115803911169a2f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.83e-05 | 169 | 194 | 6 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 170 | 194 | 6 | e08a6c5ac34c456da8c7318f104e06fca585be1f | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|Endothelial_cells / Location, Cell class and cell subclass | 1.05e-04 | 171 | 194 | 6 | dcb6c41980008d0b9eeb54999faff77311554976 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.05e-04 | 171 | 194 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 172 | 194 | 6 | 84d16cd7f618c94888920680bdc9e7130d73fd75 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 172 | 194 | 6 | f6b4754a7e4b3e38030316a0ae00d932bfa87e41 | |
| Drug | Methocarbamol [532-03-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A | ATAD5 SLC25A37 ADCY9 FBXL18 TPST1 TRIM2 WNT7B ZNF365 HSD17B6 DNAAF1 | 4.89e-06 | 195 | 186 | 10 | 7467_DN |
| Drug | Ofloxacin [82419-36-1]; Down 200; 11uM; PC3; HT_HG-U133A | 5.11e-06 | 196 | 186 | 10 | 3673_DN | |
| Drug | zoniporide | 1.83e-05 | 7 | 186 | 3 | ctd:C424422 | |
| Drug | GSK835726 | 2.81e-05 | 22 | 186 | 4 | CID005311268 | |
| Drug | AC1L9FX4 | 2.89e-05 | 44 | 186 | 5 | CID000444209 | |
| Drug | Fungal Polysaccharides | 3.20e-05 | 74 | 186 | 6 | ctd:D062610 | |
| Drug | Sulfaguanidine [57-67-0]; Down 200; 18.6uM; PC3; HG-U133A | 3.81e-05 | 198 | 186 | 9 | 1913_DN | |
| Drug | 2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one | 4.35e-05 | 9 | 186 | 3 | ctd:C539142 | |
| Drug | Pam(3)CSK(4) peptide | 4.77e-05 | 25 | 186 | 4 | ctd:C508075 | |
| Drug | mustard oil | 6.17e-05 | 10 | 186 | 3 | ctd:C027793 | |
| Drug | pimaric acid | 6.17e-05 | 10 | 186 | 3 | ctd:C008911 | |
| Drug | Vanadates | ACACA ATAD5 MCF2L2 FAM98B TLR6 CENPK SLC25A37 ADCY9 JUP FBP1 ANTXR2 ATXN1 GLI3 KCNMA1 CPLANE1 FAM135A PCDHB12 AOX1 ZNF365 KIF20B TG ZNF708 MAPK1 MAPK3 CTSV | 6.18e-05 | 1302 | 186 | 25 | ctd:D014638 |
| Drug | N-acetyl glycine cysteine amide | 6.64e-05 | 2 | 186 | 2 | ctd:C510898 | |
| Drug | N-acetyl-Cys-Gly-Pro-Cys-amide | 6.64e-05 | 2 | 186 | 2 | ctd:C510899 | |
| Drug | cysteinyl-leukotriene | 6.64e-05 | 2 | 186 | 2 | ctd:C112381 | |
| Drug | NP00111 | 6.64e-05 | 2 | 186 | 2 | ctd:C530042 | |
| Drug | substance P (6-11), Tyr(6)-D-Phe(7)-D-His(9)- | 6.64e-05 | 2 | 186 | 2 | ctd:C496429 | |
| Drug | 7-methyljuglone | 6.64e-05 | 2 | 186 | 2 | ctd:C517013 | |
| Drug | sodium tetrasulfide | 6.64e-05 | 2 | 186 | 2 | ctd:C519323 | |
| Drug | B145 | 6.64e-05 | 2 | 186 | 2 | CID002734027 | |
| Drug | 2,2',4,4',5,5'-hexabrominated diphenyl ether | 6.64e-05 | 2 | 186 | 2 | ctd:C478854 | |
| Drug | CGP 56999A | 6.64e-05 | 2 | 186 | 2 | ctd:C102659 | |
| Drug | AG 127 | 6.64e-05 | 2 | 186 | 2 | ctd:C069028 | |
| Drug | NF023 | 6.64e-05 | 2 | 186 | 2 | ctd:C105374 | |
| Drug | tyrphostin 51 | 6.64e-05 | 2 | 186 | 2 | ctd:C118515 | |
| Drug | L 759656 | 6.64e-05 | 2 | 186 | 2 | ctd:C118949 | |
| Disease | Liver carcinoma | ACACA IQGAP2 FANCD2 ARID1B FBP1 FBXL18 GPR158 EPS8L3 SKP2 CKAP2L CSMD1 ENO1 | 6.40e-05 | 507 | 178 | 12 | C2239176 |
| Disease | reticulocyte count | TMEM120B HK1 IQGAP2 BIRC6 ADCY3 SLC25A37 DOCK5 FBXL18 AP1B1 ATXN1 USP32 HERC1 MED12 TRIM2 HECTD4 OR6P1 THADA MMAB | 6.65e-05 | 1045 | 178 | 18 | EFO_0007986 |
| Disease | Hypopigmentation disorder | 1.08e-04 | 3 | 178 | 2 | C0162835 | |
| Disease | mean platelet volume | TMEM120B IQGAP2 ATAD5 ANKMY1 SLC25A37 DOCK5 ESYT2 FBXL18 AP1B1 DIAPH1 DOCK8 LRRC8D MAPRE1 FRY CKAP2L MMAB CTSS | 1.58e-04 | 1020 | 178 | 17 | EFO_0004584 |
| Disease | Global developmental delay | 1.61e-04 | 133 | 178 | 6 | C0557874 | |
| Disease | Malignant neoplasm of breast | PDE2A MCF2L2 ARID1B NF1 HERC2 MED12 GOLGB1 TRAPPC8 SLAMF1 ZNF365 EPG5 TRAPPC12 WDCP MACF1 USP54 ENO1 TP53BP1 | 2.89e-04 | 1074 | 178 | 17 | C0006142 |
| Disease | mean corpuscular hemoglobin concentration | HK1 IQGAP2 SLC25A37 ADCY9 ZGPAT AGO4 ATXN1 PREX1 GOLGB1 HECTD4 SKP2 OR6P1 HSD17B6 MACF1 MMAB SLC25A28 XPO7 | 4.00e-04 | 1105 | 178 | 17 | EFO_0004528 |
| Disease | obsolete_red blood cell distribution width | ADAD1 HK1 BIRC6 SLC25A37 ADCY9 DOCK5 ZGPAT GPR158 PDS5A HERC1 WDFY1 DOCK8 HECTD4 APOB SKP2 EPG5 WDCP HSD17B6 MMAB | 5.30e-04 | 1347 | 178 | 19 | EFO_0005192 |
| Disease | glucagon measurement, glucose tolerance test | 5.34e-04 | 6 | 178 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | CEROID LIPOFUSCINOSIS, NEURONAL, 6 | 5.34e-04 | 6 | 178 | 2 | C1866282 | |
| Disease | Streptococcal pneumonia | 5.34e-04 | 6 | 178 | 2 | C0155862 | |
| Disease | Ciliopathies | 5.54e-04 | 110 | 178 | 5 | C4277690 | |
| Disease | platelet crit | TMEM120B HK1 IQGAP2 SLC25A37 ZGPAT NF1 PREX1 FHIP1A PGBD2 APOB EPG5 LMAN1L THADA HSD17B6 ENO1 | 6.92e-04 | 952 | 178 | 15 | EFO_0007985 |
| Disease | mammographic density percentage | 7.03e-04 | 29 | 178 | 3 | EFO_0006502 | |
| Disease | Child Development Disorders, Specific | 7.03e-04 | 29 | 178 | 3 | C0085997 | |
| Disease | Child Development Deviations | 7.03e-04 | 29 | 178 | 3 | C0085996 | |
| Disease | Polydactyly | 7.34e-04 | 117 | 178 | 5 | C0152427 | |
| Disease | Obesity, Morbid | 7.45e-04 | 7 | 178 | 2 | C0028756 | |
| Disease | endometrial adenocarcinoma (is_implicated_in) | 7.45e-04 | 7 | 178 | 2 | DOID:2870 (is_implicated_in) | |
| Disease | Developmental Disabilities | 7.77e-04 | 30 | 178 | 3 | C0008073 | |
| Disease | red blood cell density measurement | FAM120B HK1 ARID1B PREX1 PGBD2 WNT7B KIF20B TG LMAN1L LINGO1 MAPK1 MMAB SLC25A28 XPO7 | 9.51e-04 | 880 | 178 | 14 | EFO_0007978 |
| Disease | Schizophrenia | A1BG HK1 FBXL21P CBLIF FBP1 PLAA MED12 TBP NPAS2 PAH HAGH MAPK1 MAPK3 CSMD1 | 9.82e-04 | 883 | 178 | 14 | C0036341 |
| Disease | kidney disease (is_marker_for) | 9.89e-04 | 8 | 178 | 2 | DOID:557 (is_marker_for) | |
| Disease | Autistic Disorder | 1.08e-03 | 261 | 178 | 7 | C0004352 | |
| Disease | endometrial carcinoma (is_marker_for) | 1.13e-03 | 34 | 178 | 3 | DOID:2871 (is_marker_for) | |
| Disease | mean reticulocyte volume | TMEM120B HK1 IQGAP2 ADCY9 PREX1 GOLGB1 SKP2 OR6P1 THADA HSD17B6 MMAB PMFBP1 XPO7 | 1.18e-03 | 799 | 178 | 13 | EFO_0010701 |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 1.23e-03 | 35 | 178 | 3 | DOID:0050861 (is_implicated_in) | |
| Disease | ureteral obstruction (implicated_via_orthology) | 1.27e-03 | 9 | 178 | 2 | DOID:5199 (implicated_via_orthology) | |
| Disease | alcohol drinking | 1.48e-03 | 81 | 178 | 4 | EFO_0004329 | |
| Disease | endometrial hyperplasia (is_marker_for) | 1.58e-03 | 10 | 178 | 2 | DOID:0080365 (is_marker_for) | |
| Disease | 2-aminobutyrate measurement | 1.58e-03 | 10 | 178 | 2 | EFO_0020017 | |
| Disease | Intellectual Disability | 1.65e-03 | 447 | 178 | 9 | C3714756 | |
| Disease | reticulocyte measurement | TMEM120B HK1 IQGAP2 BIRC6 ADCY3 SLC25A37 DOCK5 AP1B1 ATXN1 USP32 PREX1 MED12 TRIM2 HECTD4 MMAB | 1.88e-03 | 1053 | 178 | 15 | EFO_0010700 |
| Disease | Enzymopathy | 1.92e-03 | 11 | 178 | 2 | C0520572 | |
| Disease | endometrial adenocarcinoma (is_marker_for) | 1.92e-03 | 11 | 178 | 2 | DOID:2870 (is_marker_for) | |
| Disease | depressive symptom measurement, response to antidepressant | 2.01e-03 | 88 | 178 | 4 | EFO_0007006, GO_0036276 | |
| Disease | platelet component distribution width | TMEM120B IQGAP2 DOCK5 CEP68 PDS5A HERC1 PREX1 NPAS2 DOCK8 LMAN1L MACF1 XPO7 | 2.20e-03 | 755 | 178 | 12 | EFO_0007984 |
| Disease | Trigeminal Neuralgia | 2.30e-03 | 12 | 178 | 2 | C0040997 | |
| Disease | Secondary Trigeminal Neuralgia | 2.30e-03 | 12 | 178 | 2 | C0393787 | |
| Disease | Trigeminal Neuralgia, Idiopathic | 2.30e-03 | 12 | 178 | 2 | C0393786 | |
| Disease | Malignant Head and Neck Neoplasm | 2.38e-03 | 44 | 178 | 3 | C0278996 | |
| Disease | age at menopause | 2.47e-03 | 302 | 178 | 7 | EFO_0004704 | |
| Disease | gastric ulcer (implicated_via_orthology) | 3.14e-03 | 14 | 178 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 3.14e-03 | 14 | 178 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 3.24e-03 | 49 | 178 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | mammographic density measurement | 3.44e-03 | 50 | 178 | 3 | EFO_0005941 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 3.44e-03 | 50 | 178 | 3 | EFO_0022247 | |
| Disease | phospholipids in very small VLDL measurement | 3.63e-03 | 51 | 178 | 3 | EFO_0022300 | |
| Disease | pancreatic ductal carcinoma (is_implicated_in) | 4.11e-03 | 16 | 178 | 2 | DOID:3587 (is_implicated_in) | |
| Disease | S-7-hydroxywarfarin measurement | 4.50e-03 | 110 | 178 | 4 | EFO_0803329 | |
| Disease | urate measurement, bone density | GALNT18 DOCK5 DIAPH1 KCNMA1 UTRN FAM135A TG HEATR6 LINGO1 IGKC | 4.52e-03 | 619 | 178 | 10 | EFO_0003923, EFO_0004531 |
| Disease | granulocyte count | 4.55e-03 | 254 | 178 | 6 | EFO_0007987 | |
| Disease | response to phenylephrine | 4.64e-03 | 17 | 178 | 2 | EFO_0010152 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 4.64e-03 | 17 | 178 | 2 | C2936862 | |
| Disease | Astrocytosis | 4.64e-03 | 17 | 178 | 2 | C3887640 | |
| Disease | Gliosis | 4.64e-03 | 17 | 178 | 2 | C0017639 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 4.64e-03 | 17 | 178 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | immature platelet fraction | 5.10e-03 | 114 | 178 | 4 | EFO_0009187 | |
| Disease | Hypertrophy | 5.20e-03 | 18 | 178 | 2 | C0020564 | |
| Disease | Bardet-Biedl syndrome | 5.20e-03 | 18 | 178 | 2 | cv:C0752166 | |
| Disease | Neoplasm Invasiveness | 5.28e-03 | 184 | 178 | 5 | C0027626 | |
| Disease | cholesterol to total lipids in IDL percentage | 5.74e-03 | 60 | 178 | 3 | EFO_0022233 | |
| Disease | cardiomyopathy (is_implicated_in) | 5.78e-03 | 19 | 178 | 2 | DOID:0050700 (is_implicated_in) | |
| Disease | cerebral infarction (is_marker_for) | 5.78e-03 | 19 | 178 | 2 | DOID:3526 (is_marker_for) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 6.01e-03 | 61 | 178 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KQNLLLACLVISSVT | 6 | O60507 | |
| QCLNDVLGKKLNTST | 771 | Q96QE3 | |
| CSLGNLKVPLSQLLT | 611 | A0FGR8 | |
| KDATQLVCTDLNLLQ | 1531 | Q9HCE0 | |
| LGLSLQICLTKNSTL | 551 | Q76B58 | |
| QICLTKNSTLEPVLA | 556 | Q76B58 | |
| CEILKSIIGNQSISL | 251 | Q5JVX7 | |
| LLNTLCRKTDDGQIT | 1331 | Q9NR09 | |
| DILTCKLSSQLQFEG | 2296 | Q96PZ7 | |
| LTESVLQKGEILLQC | 681 | Q76N32 | |
| QLLGVTSLLIACKQV | 176 | P22674 | |
| GKLVSLSEQNLVDCS | 156 | O60911 | |
| CSLLVQKLNLTDTGR | 386 | Q2WEN9 | |
| EKTPLTLSQLCRVNL | 236 | Q8WXK3 | |
| QTLSNLCLKINVKLG | 556 | Q9UL18 | |
| LKGIINSILAQSCTE | 206 | P58335 | |
| CIENLQKLILSETSI | 1116 | Q13085 | |
| CTEPTSNLLTLKQNI | 306 | Q96M93 | |
| AETQKLLCKNGETLL | 186 | P53365 | |
| LVLETLCKLSIQDNN | 2151 | Q8NFD5 | |
| TQLSASCVQLLGLLS | 111 | Q0P5N6 | |
| PQSINKLLTALNECT | 201 | Q10567 | |
| LCLGLDNSGKTTIIN | 21 | Q9H0F7 | |
| TSPQTLSNLCLKINV | 556 | Q9H9G7 | |
| KTSPQTLSNLCLKIN | 546 | Q9HCK5 | |
| LSVGDVCISLTLKNL | 676 | P54253 | |
| TTIALKVGCLQLINA | 306 | O60610 | |
| ILAVGNCTLNLLSKE | 371 | Q06278 | |
| LTDNENCLKAVTLSL | 471 | Q9HC84 | |
| SQLELLISPTCSCKQ | 571 | Q29RF7 | |
| QGDCEKLNITTSNLI | 1271 | Q9H0J4 | |
| LDTKTEACQLGLLQS | 961 | A6NNM3 | |
| LDTKTEACQLGLLQS | 961 | A6NJZ7 | |
| TGSQNVQLCTAILKL | 336 | Q96EP9 | |
| SSCDLTQQLLPQTVL | 471 | Q99743 | |
| ESLLKPLANVTLTCQ | 36 | P04217 | |
| IKLQCKTVGLLSNIS | 756 | Q7Z5J8 | |
| QLAICSSLQNLEKTI | 136 | Q96K31 | |
| KPSNLLLNTTCDLKI | 151 | P28482 | |
| ELQTCLIKEQLSQLS | 656 | Q96RG2 | |
| NLTLDCLTAKLSGLQ | 536 | Q9NPJ1 | |
| LQKISSDICNLKGIQ | 591 | A4D1F6 | |
| LGKLSTQISTLECNF | 1346 | Q9NU22 | |
| SCLLQGTSAKNSELL | 1466 | P10071 | |
| ETLSTNCIPIKNGSL | 286 | Q6P0N0 | |
| TSLQDKECILASLNI | 936 | Q12791 | |
| SLLIGCQVTGKLLQT | 206 | P78508 | |
| SSVCQNLEKQISLIG | 546 | Q5T848 | |
| STINLLQTLCLSAGV | 1966 | O95714 | |
| VLSAKLDSLQTLNAC | 271 | Q96T76 | |
| STLQVGSLNVKCLAT | 141 | Q16775 | |
| TGTQLCKALVLEQLT | 126 | O95998 | |
| ELNKSLQECLSTGSL | 486 | Q9HAT1 | |
| EVLLNIASQKCSSGI | 1931 | Q15751 | |
| LINALGSNTCLAKVD | 561 | Q8ND23 | |
| ITSTKLNNQCELLSQ | 1301 | Q3V6T2 | |
| LLGKQGTTLLSCIQE | 256 | Q86YR7 | |
| LNLCANLSISGKLDI | 606 | Q9P2D6 | |
| LVCSGLLQASKSNLI | 256 | Q9UHG3 | |
| EFVLLGLCSSQKLQL | 11 | Q8NGD3 | |
| LVSEDNLQLSCKVIG | 266 | O00408 | |
| LLTPKAINLLQSCLS | 341 | Q8TE67 | |
| SQEELIQCLKQGALS | 196 | O75037 | |
| GNINTSLLTLGKCIN | 401 | Q96Q89 | |
| SLLTLGKCINVLKNS | 406 | Q96Q89 | |
| DTSSLIINNKLICNE | 801 | Q96Q89 | |
| CALQVLSAILEGSKQ | 476 | Q6AI08 | |
| PLDVCKTLLNTQESL | 281 | Q96A46 | |
| LEVAKSLSALIGQCI | 221 | Q86TG7 | |
| LENVLGCTSLDTKTI | 531 | Q8NG66 | |
| LSQCPSISQLKTLDL | 316 | P0DUQ1 | |
| ETQLKTLCQFPETLL | 116 | P22001 | |
| NSLEQLTLEKCNLTS | 191 | Q96FE5 | |
| LSQQPFLSLVLTCLK | 1476 | Q93074 | |
| LVLNSVLSKALQCSL | 1556 | Q96RT7 | |
| DLKPSNLLINTTCDL | 166 | P27361 | |
| LQEKSSLLCLDLGLN | 921 | Q9NX02 | |
| VLTCSKTLQQLNLTL | 916 | Q96MN2 | |
| QGEESLLELTKQICS | 2546 | Q9Y4D8 | |
| ALNLSLCKQITDSSL | 121 | Q8N1E6 | |
| QLTLQDCQKLTDLSL | 206 | Q8N1E6 | |
| QLGLNSTCDDSILVK | 806 | P19367 | |
| NPKFLAITTDCLQLL | 281 | P14923 | |
| SINSEIGILCSALQK | 436 | P00439 | |
| NLSLCLTLKPEENLS | 3081 | Q9UPN3 | |
| LCGTLKSEIATQELT | 3226 | Q9UPN3 | |
| NKECLQLDTNTGDLL | 71 | Q9Y5F1 | |
| LLQNKVPLLGSSTAC | 126 | Q8NI37 | |
| LTQLLNSLCTAVKAI | 31 | P09467 | |
| ISPLLNLTCSDKEQA | 181 | Q8NGX9 | |
| VENLLLSNQGTIKLC | 176 | O14976 | |
| QIGSVTESLQACKLA | 346 | P06733 | |
| ATTNLKCSLLVLENE | 1656 | P04114 | |
| LNQLCSILAKDPSIL | 166 | Q05DH4 | |
| SLAILALCQKNSEAT | 136 | P27352 | |
| KEGLLNCSTNLNLVT | 251 | O14756 | |
| STLFNLGLTKCNSLV | 646 | Q96M89 | |
| ICSTKLTQNVDLLGL | 626 | Q9H7D0 | |
| CSQLSAKLSNLPTLI | 1076 | Q8NF50 | |
| LQSTGDCLNQTLELK | 816 | Q9H799 | |
| LSQLVNCSLKTLGLI | 131 | Q9UKT7 | |
| CETGKQLALLKTNSA | 81 | Q13347 | |
| EECQNKLSLIGTETL | 36 | Q9BS16 | |
| GVLQNSLKTDLCLDQ | 471 | Q6P9A2 | |
| VEDLGSKILLTCSLN | 146 | P35613 | |
| TCEKLGQLNIDISNI | 71 | P32189 | |
| LSSACSAQELVKLLN | 331 | O60266 | |
| TNSQTSLCEILQEKG | 686 | O60503 | |
| QLIKLCTQIPSGFSL | 101 | Q9P2S6 | |
| GSQIKSLCNLEESIT | 56 | Q52LJ0 | |
| ESLQLNLTKIEQLCS | 26 | Q15691 | |
| EQLKSGTASVVCLLN | 16 | P01834 | |
| CLVTQSLEKLQVLNG | 636 | Q6ZW76 | |
| KTIENLSCLPVLNTL | 186 | Q8NEP3 | |
| TGKLVSLSAQNLVDC | 156 | P25774 | |
| KTLNLGSCVIATNLQ | 26 | Q9NYY1 | |
| SLSNPLNCSVKTVLQ | 876 | Q9H583 | |
| KTLQCLNIPEINSLI | 906 | Q6PJP8 | |
| NLSDCLKNSDLLTVL | 1921 | Q5TBA9 | |
| LKISTNSVVTGCLQL | 1126 | P82279 | |
| ILKSNNPAITTAECL | 216 | Q8ND90 | |
| KTLGQETLCSLQEAD | 146 | Q96EK7 | |
| ALCLQGKSTSQLVNL | 746 | Q96EK7 | |
| TSQESGQKLVSPLCL | 716 | Q9BXW9 | |
| QLSQLTQLELKGNCL | 796 | Q7L1W4 | |
| KIQCTLQDVGSALAT | 116 | Q96EY8 | |
| VNCSIQTLGLISTAK | 141 | Q9UKT6 | |
| QSSLSNIELLECQVK | 186 | Q8TBY8 | |
| SLKDSCQRELTNLLG | 836 | P46939 | |
| CITGALQKLSLNSLQ | 926 | Q6YHU6 | |
| CSKDANDTLLLQLTN | 121 | P0CF51 | |
| QKLEELAALQTLCSS | 31 | A0PK00 | |
| TNLVILCTGIKINSS | 236 | Q9BRQ8 | |
| SLVKLQCLDLSDNAL | 86 | Q86X40 | |
| LCSVLKASGSLQQLS | 606 | Q15345 | |
| LDTKTEACQLGLLQS | 961 | Q9UFD9 | |
| QNSILANIILSCLKP | 1381 | Q8IVG5 | |
| NQCLEGKKSSDILSV | 546 | Q13576 | |
| GESLATCKSLQQSLL | 651 | Q96ME1 | |
| ETQKFCLTPRLSLQL | 441 | Q5UE93 | |
| ATTPLDVCKTLLNTQ | 251 | Q9NYZ2 | |
| LKTSLNILAITNCVL | 291 | Q5VT98 | |
| LSQCPSISQLKTLDL | 316 | A6NGN4 | |
| TDICTQLLLQGTLLK | 266 | Q8TCU6 | |
| IKVLNKTQENGTCTL | 146 | Q13291 | |
| LNLTSELLQKCSSPA | 26 | Q86TU7 | |
| QLVPAKLLNSSCSLE | 6 | Q8N7X8 | |
| LSQCPSISQLKTLDL | 316 | A3QJZ7 | |
| IALTLQVCGTLSSLQ | 746 | Q9BVR0 | |
| QLKISQGNISKACLI | 381 | O76094 | |
| NALGKTLVQLLTCSP | 1151 | O60287 | |
| ITSETGKALIQTCLN | 206 | P11831 | |
| SLQICLTKNSTLEPV | 571 | Q9C0B6 | |
| ELSSKINNTLTECLN | 516 | Q8IYA6 | |
| TSQENCLKEGSTLLQ | 136 | Q6UXN8 | |
| QECALLITKPNFIST | 76 | A5YKK6 | |
| NLSLTAQELKCVLGI | 171 | Q6P3X8 | |
| TNEIQSNLKCLGLLE | 1211 | Q9BXT8 | |
| ILSQCSKLQNLSLEG | 201 | Q13309 | |
| LSQCPSISQLKTLDL | 316 | O60810 | |
| QCPSISQLKTLDLSG | 316 | Q5VXH4 | |
| LSSVVALGANIICNK | 26 | P56706 | |
| SALLLNSCKIPLSDN | 166 | Q6P9A3 | |
| SLKNQCLATLPDLKT | 46 | Q99973 | |
| SLENQCLATLSDLKT | 76 | Q99973 | |
| CTQELVNLLLTGKAV | 601 | Q4G0A6 | |
| FCQLLKLQTSDELLT | 271 | Q6NUQ1 | |
| TVCSKILANLEQGLA | 506 | Q8WVT3 | |
| QNIVSTVNLGCKLDL | 166 | P20226 | |
| LSQCPSISQLKTLDL | 316 | P0DUQ2 | |
| LVLDKCTNLSEGVLS | 281 | Q93063 | |
| GKAQCLSLISTILEV | 721 | Q9Y263 | |
| QCPSISQLKTLDLSG | 316 | Q5TYX0 | |
| LSTICLLNGFQAIKL | 136 | Q9GZP7 | |
| CSSTQGELQLKLDLL | 611 | Q6ZS81 | |
| TCTFNLKIEGQLLET | 1881 | P21359 | |
| LDSKINTLLSLCQDP | 2661 | P21359 | |
| LSQCPSISQLKTLDL | 316 | O60813 | |
| LIVQEGKNLTINCTS | 31 | A0A0B4J273 | |
| QLKSQDSPEISSLCQ | 821 | Q2M1Z3 | |
| LSLTETQSQGLCLQK | 691 | Q12888 | |
| ALLLCQNKGLLETTV | 641 | O43290 | |
| LSFLKCLNLSGNLIS | 516 | Q9NYK1 | |
| SVNTLGCLQLTNIKL | 216 | Q9Y2C9 | |
| AVSNLDLITCLEQGK | 46 | P17019 | |
| LPLTNSQLSLKVDSC | 81 | O14863 | |
| CEPITSKTLQLLNDL | 606 | Q9UIA9 | |
| ELTRCLQGKSSQLLQ | 126 | Q86WZ6 | |
| QKSLCLVPVTLLLSN | 1326 | Q9Y2L5 | |
| QNCVIGKLTIIDLLT | 181 | Q70YC4 | |
| VLSCSQALKIVDNLG | 326 | Q6PGP7 | |
| LDTLLQGQESIKSCS | 241 | Q9C040 | |
| LLCDGKLRLSTVQQT | 621 | Q9H6R7 | |
| QLKGGEVTCLTLNSL | 2016 | P01266 | |
| SGQITLLKLEQNTCS | 176 | Q8IWB7 | |
| GKSLDQCVETLQKQT | 371 | Q8N5A5 | |
| KQLSDLCGLNSEQIL | 951 | Q8NFA0 | |
| CQKLTLADLISQGTE | 101 | A6NCI4 | |
| QEKCKSILLQSLIEG | 436 | Q7Z3T8 | |
| CLQGQSLKTSLTLKV | 1096 | Q70EL1 | |
| ILSLQKTGQELQSAC | 381 | Q14789 | |
| SQLLEEKNTLSIQLC | 3056 | Q14789 | |
| NLGIEQVCSLISSDK | 196 | O95198 | |
| QISRIEGLNTLTKLC | 76 | Q9C099 | |
| EGLNTLTKLCTLNLS | 81 | Q9C099 | |
| TLNLSCNLITKVEGL | 91 | Q9C099 |